HAVCR2 and neoplasm: In stark contrast, tumor-infiltrating lymphocytes exhibited a markedly higher frequency of PD-1+Tim-3+ cells, representing more than a 4-fold increase compared to peripheral levels (HD: 1.1%; treatment-naïve: 2.8%; treated: 2.7%; TILs: 11.7%).